Home » Topics » Regulatory

Regulatory
RSS

BioMarin's amifampridine phosphate approved in the EU for LEMS

Jan. 7, 2010

Novartis' Onbrez Breezhaler approved in E.U. for patients with COPD

Dec. 4, 2009

Kalbitor approved in U.S. for hereditary angioedema

Dec. 3, 2009

FDA approves Cymbalta for maintenance treatment of GAD

Dec. 1, 2009

Angiox approved in E.U. for additional indication

Dec. 1, 2009

France grants marketing authorization to Sanofi's Panenza influenza vaccine

Nov. 18, 2009

FDA approves Lysteda for the treatment of menorrhagia

Nov. 17, 2009

Shire launches Intuniv in the U.S. for ADHD in children and adolescents

Nov. 9, 2009

FDA approves Gloucester's Istodax for cutaneous T-cell lymphoma

Nov. 9, 2009

Novartis' influenza A(H1N1) vaccine Celtura approved in Germany

Nov. 6, 2009

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 7, 2025
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...